02Apr/13

Consider being an organ donor – Post Searchlight


Kilkenny People

Consider being an organ donor
Post Searchlight
April is National Donate Life Month, and we’d like to encourage everyone to consider being an organ, eye or tissue donor. More than 3,700 people living in Georgia are currently waiting for a potentially life-saving transplant, and a new patient is
PennDOT Encourages Organ DonationYourErie
Seamus from Kells helps launch Organ Donor Awareness WeekKilkenny People
McCrory proclaims April as Organ Donation Awareness MonthTriangle Business Journal (blog)
Chicago Tribune –Mountain Xpress –Superior Telegram
all 48 news articles »
02Apr/13

Former Medical College of Wisconsin intern loses appeal of her whistle-blower … – Milwaukee Journal Sentinel


WisBar

Former Medical College of Wisconsin intern loses appeal of her whistle-blower
Milwaukee Journal Sentinel
According to the opinion, Asma Masri was a doctoral candidate at University of Wisconsin-Milwaukee when she began an internship at the Medical College of Wisconsin, assigned to the transplant surgery unit at Froedtert Hospital. She worked 40 hours a
Medical Intern’s Retaliation Claims Not Covered by Health Care Worker StatuteWisBar

all 2 news articles »

02Apr/13

Heart Failure Doesn't Discriminate – Science Daily (press release)


MedPage Today

Heart Failure Doesn’t Discriminate
Science Daily (press release)
Heart failure is a disease of the aging, and on average, black men in America tend to have higher competing risks for death earlier in life,” Huffman said. “Because competing risks are higher, which is itself a major problem, relatively fewer black
Do Black Men Face Lower Risk of Heart Failure?MedPage Today

all 2 news articles »

02Apr/13

Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI® – Financial Post

Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI®
Financial Post
Biogen Idec also has the deepest MS pipeline in the industry with compounds that include PLEGRIDY™ (peginterferon beta-1a); daclizumab high-yield process (DAC HYP) for monthly subcutaneous administration; and an ongoing study with TYSABRI as a

and more »